MHRA Contraindicates Domperidone in Phaeochromocytoma Dr Sheena Meredith

https://www.medscape.com/viewarticle/mhra-contraindicates-domperidone-phaeochromocytoma-2026a1000otk?src= Domperidone is now contraindicated in patients with confirmed or suspected phaeochromocytoma because of the risk of severe hypertension, the Medicines and Healthcare products Regulatory Agency (MHRA) has said in a new drug safety update. The update follows a European review of domperidone safety data that identified four reports of severe hypertension in these patients.